Global Tumor Multigene Detection Kit Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Tumor Multigene Detection Kit market size is projected to grow from US$ 857.9 million in 2022 to US$ 2513.5 million in 2029; it is expected to grow at a CAGR of 16.6% from 2023 to 2029.
United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Tumor NGS detection kit is an experimental consumable used in tumor detection
LPI (LP Information)' newest research report, the “Tumor Multigene Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2023 through 2029. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tumor Multigene Detection Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Tumor Multigene Detection Kit market?
What factors are driving Tumor Multigene Detection Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tumor Multigene Detection Kit market opportunities vary by end market size?
How does Tumor Multigene Detection Kit break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Tumor Multigene Detection Kit market size is projected to grow from US$ 857.9 million in 2022 to US$ 2513.5 million in 2029; it is expected to grow at a CAGR of 16.6% from 2023 to 2029.
United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Tumor NGS detection kit is an experimental consumable used in tumor detection
LPI (LP Information)' newest research report, the “Tumor Multigene Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2023 through 2029. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.
This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tumor Multigene Detection Kit market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Reversible End Termination Sequencing
- Semiconductor Sequencing
- Combined Probe Anchored Polymerization Sequencing
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Foundation Medicine
- Illumina Inc.
- Life Technologies Corporation
- Thermo Fisher Scientific
- Memorial Sloan Kettering
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- NantHealth
- Personal Genome Diagnostics
- GTH.O
What is the 10-year outlook for the global Tumor Multigene Detection Kit market?
What factors are driving Tumor Multigene Detection Kit market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tumor Multigene Detection Kit market opportunities vary by end market size?
How does Tumor Multigene Detection Kit break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Multigene Detection Kit Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tumor Multigene Detection Kit by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tumor Multigene Detection Kit by Country/Region, 2018, 2022 & 2029
2.2 Tumor Multigene Detection Kit Segment by Type
2.2.1 Reversible End Termination Sequencing
2.2.2 Semiconductor Sequencing
2.2.3 Combined Probe Anchored Polymerization Sequencing
2.3 Tumor Multigene Detection Kit Sales by Type
2.3.1 Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
2.3.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tumor Multigene Detection Kit Sale Price by Type (2018-2023)
2.4 Tumor Multigene Detection Kit Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Early Cancer Screening
2.4.3 Drug Discovery
2.4.4 Other
2.5 Tumor Multigene Detection Kit Sales by Application
2.5.1 Global Tumor Multigene Detection Kit Sale Market Share by Application (2018-2023)
2.5.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tumor Multigene Detection Kit Sale Price by Application (2018-2023)
3 GLOBAL TUMOR MULTIGENE DETECTION KIT BY COMPANY
3.1 Global Tumor Multigene Detection Kit Breakdown Data by Company
3.1.1 Global Tumor Multigene Detection Kit Annual Sales by Company (2018-2023)
3.1.2 Global Tumor Multigene Detection Kit Sales Market Share by Company (2018-2023)
3.2 Global Tumor Multigene Detection Kit Annual Revenue by Company (2018-2023)
3.2.1 Global Tumor Multigene Detection Kit Revenue by Company (2018-2023)
3.2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Company (2018-2023)
3.3 Global Tumor Multigene Detection Kit Sale Price by Company
3.4 Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Multigene Detection Kit Product Location Distribution
3.4.2 Players Tumor Multigene Detection Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Multigene Detection Kit Market Size by Geographic Region (2018-2023)
4.1.1 Global Tumor Multigene Detection Kit Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tumor Multigene Detection Kit Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tumor Multigene Detection Kit Market Size by Country/Region (2018-2023)
4.2.1 Global Tumor Multigene Detection Kit Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tumor Multigene Detection Kit Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tumor Multigene Detection Kit Sales Growth
4.4 APAC Tumor Multigene Detection Kit Sales Growth
4.5 Europe Tumor Multigene Detection Kit Sales Growth
4.6 Middle East & Africa Tumor Multigene Detection Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Multigene Detection Kit Sales by Country
5.1.1 Americas Tumor Multigene Detection Kit Sales by Country (2018-2023)
5.1.2 Americas Tumor Multigene Detection Kit Revenue by Country (2018-2023)
5.2 Americas Tumor Multigene Detection Kit Sales by Type
5.3 Americas Tumor Multigene Detection Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Multigene Detection Kit Sales by Region
6.1.1 APAC Tumor Multigene Detection Kit Sales by Region (2018-2023)
6.1.2 APAC Tumor Multigene Detection Kit Revenue by Region (2018-2023)
6.2 APAC Tumor Multigene Detection Kit Sales by Type
6.3 APAC Tumor Multigene Detection Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Multigene Detection Kit by Country
7.1.1 Europe Tumor Multigene Detection Kit Sales by Country (2018-2023)
7.1.2 Europe Tumor Multigene Detection Kit Revenue by Country (2018-2023)
7.2 Europe Tumor Multigene Detection Kit Sales by Type
7.3 Europe Tumor Multigene Detection Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Multigene Detection Kit by Country
8.1.1 Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2018-2023)
8.2 Middle East & Africa Tumor Multigene Detection Kit Sales by Type
8.3 Middle East & Africa Tumor Multigene Detection Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit
10.3 Manufacturing Process Analysis of Tumor Multigene Detection Kit
10.4 Industry Chain Structure of Tumor Multigene Detection Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Multigene Detection Kit Distributors
11.3 Tumor Multigene Detection Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Multigene Detection Kit Market Size Forecast by Region
12.1.1 Global Tumor Multigene Detection Kit Forecast by Region (2024-2029)
12.1.2 Global Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tumor Multigene Detection Kit Forecast by Type
12.7 Global Tumor Multigene Detection Kit Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche Foundation Medicine
13.1.1 Roche Foundation Medicine Company Information
13.1.2 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Foundation Medicine Main Business Overview
13.1.5 Roche Foundation Medicine Latest Developments
13.2 Illumina Inc.
13.2.1 Illumina Inc. Company Information
13.2.2 Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
13.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Illumina Inc. Main Business Overview
13.2.5 Illumina Inc. Latest Developments
13.3 Life Technologies Corporation
13.3.1 Life Technologies Corporation Company Information
13.3.2 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
13.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Life Technologies Corporation Main Business Overview
13.3.5 Life Technologies Corporation Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Memorial Sloan Kettering
13.5.1 Memorial Sloan Kettering Company Information
13.5.2 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
13.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Memorial Sloan Kettering Main Business Overview
13.5.5 Memorial Sloan Kettering Latest Developments
13.6 Novogene
13.6.1 Novogene Company Information
13.6.2 Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
13.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novogene Main Business Overview
13.6.5 Novogene Latest Developments
13.7 Geneseeq
13.7.1 Geneseeq Company Information
13.7.2 Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
13.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Geneseeq Main Business Overview
13.7.5 Geneseeq Latest Developments
13.8 AmoyDx
13.8.1 AmoyDx Company Information
13.8.2 AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
13.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AmoyDx Main Business Overview
13.8.5 AmoyDx Latest Developments
13.9 Burning Rock Medicine
13.9.1 Burning Rock Medicine Company Information
13.9.2 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Burning Rock Medicine Main Business Overview
13.9.5 Burning Rock Medicine Latest Developments
13.10 NantHealth
13.10.1 NantHealth Company Information
13.10.2 NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
13.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NantHealth Main Business Overview
13.10.5 NantHealth Latest Developments
13.11 Personal Genome Diagnostics
13.11.1 Personal Genome Diagnostics Company Information
13.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
13.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Personal Genome Diagnostics Main Business Overview
13.11.5 Personal Genome Diagnostics Latest Developments
13.12 GTH.O
13.12.1 GTH.O Company Information
13.12.2 GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
13.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 GTH.O Main Business Overview
13.12.5 GTH.O Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tumor Multigene Detection Kit Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tumor Multigene Detection Kit by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tumor Multigene Detection Kit by Country/Region, 2018, 2022 & 2029
2.2 Tumor Multigene Detection Kit Segment by Type
2.2.1 Reversible End Termination Sequencing
2.2.2 Semiconductor Sequencing
2.2.3 Combined Probe Anchored Polymerization Sequencing
2.3 Tumor Multigene Detection Kit Sales by Type
2.3.1 Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
2.3.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tumor Multigene Detection Kit Sale Price by Type (2018-2023)
2.4 Tumor Multigene Detection Kit Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Early Cancer Screening
2.4.3 Drug Discovery
2.4.4 Other
2.5 Tumor Multigene Detection Kit Sales by Application
2.5.1 Global Tumor Multigene Detection Kit Sale Market Share by Application (2018-2023)
2.5.2 Global Tumor Multigene Detection Kit Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tumor Multigene Detection Kit Sale Price by Application (2018-2023)
3 GLOBAL TUMOR MULTIGENE DETECTION KIT BY COMPANY
3.1 Global Tumor Multigene Detection Kit Breakdown Data by Company
3.1.1 Global Tumor Multigene Detection Kit Annual Sales by Company (2018-2023)
3.1.2 Global Tumor Multigene Detection Kit Sales Market Share by Company (2018-2023)
3.2 Global Tumor Multigene Detection Kit Annual Revenue by Company (2018-2023)
3.2.1 Global Tumor Multigene Detection Kit Revenue by Company (2018-2023)
3.2.2 Global Tumor Multigene Detection Kit Revenue Market Share by Company (2018-2023)
3.3 Global Tumor Multigene Detection Kit Sale Price by Company
3.4 Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tumor Multigene Detection Kit Product Location Distribution
3.4.2 Players Tumor Multigene Detection Kit Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
4.1 World Historic Tumor Multigene Detection Kit Market Size by Geographic Region (2018-2023)
4.1.1 Global Tumor Multigene Detection Kit Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tumor Multigene Detection Kit Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tumor Multigene Detection Kit Market Size by Country/Region (2018-2023)
4.2.1 Global Tumor Multigene Detection Kit Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tumor Multigene Detection Kit Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tumor Multigene Detection Kit Sales Growth
4.4 APAC Tumor Multigene Detection Kit Sales Growth
4.5 Europe Tumor Multigene Detection Kit Sales Growth
4.6 Middle East & Africa Tumor Multigene Detection Kit Sales Growth
5 AMERICAS
5.1 Americas Tumor Multigene Detection Kit Sales by Country
5.1.1 Americas Tumor Multigene Detection Kit Sales by Country (2018-2023)
5.1.2 Americas Tumor Multigene Detection Kit Revenue by Country (2018-2023)
5.2 Americas Tumor Multigene Detection Kit Sales by Type
5.3 Americas Tumor Multigene Detection Kit Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Multigene Detection Kit Sales by Region
6.1.1 APAC Tumor Multigene Detection Kit Sales by Region (2018-2023)
6.1.2 APAC Tumor Multigene Detection Kit Revenue by Region (2018-2023)
6.2 APAC Tumor Multigene Detection Kit Sales by Type
6.3 APAC Tumor Multigene Detection Kit Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tumor Multigene Detection Kit by Country
7.1.1 Europe Tumor Multigene Detection Kit Sales by Country (2018-2023)
7.1.2 Europe Tumor Multigene Detection Kit Revenue by Country (2018-2023)
7.2 Europe Tumor Multigene Detection Kit Sales by Type
7.3 Europe Tumor Multigene Detection Kit Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tumor Multigene Detection Kit by Country
8.1.1 Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2018-2023)
8.2 Middle East & Africa Tumor Multigene Detection Kit Sales by Type
8.3 Middle East & Africa Tumor Multigene Detection Kit Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit
10.3 Manufacturing Process Analysis of Tumor Multigene Detection Kit
10.4 Industry Chain Structure of Tumor Multigene Detection Kit
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tumor Multigene Detection Kit Distributors
11.3 Tumor Multigene Detection Kit Customer
12 WORLD FORECAST REVIEW FOR TUMOR MULTIGENE DETECTION KIT BY GEOGRAPHIC REGION
12.1 Global Tumor Multigene Detection Kit Market Size Forecast by Region
12.1.1 Global Tumor Multigene Detection Kit Forecast by Region (2024-2029)
12.1.2 Global Tumor Multigene Detection Kit Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tumor Multigene Detection Kit Forecast by Type
12.7 Global Tumor Multigene Detection Kit Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche Foundation Medicine
13.1.1 Roche Foundation Medicine Company Information
13.1.2 Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Foundation Medicine Main Business Overview
13.1.5 Roche Foundation Medicine Latest Developments
13.2 Illumina Inc.
13.2.1 Illumina Inc. Company Information
13.2.2 Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
13.2.3 Illumina Inc. Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Illumina Inc. Main Business Overview
13.2.5 Illumina Inc. Latest Developments
13.3 Life Technologies Corporation
13.3.1 Life Technologies Corporation Company Information
13.3.2 Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
13.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Life Technologies Corporation Main Business Overview
13.3.5 Life Technologies Corporation Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
13.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Memorial Sloan Kettering
13.5.1 Memorial Sloan Kettering Company Information
13.5.2 Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
13.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Memorial Sloan Kettering Main Business Overview
13.5.5 Memorial Sloan Kettering Latest Developments
13.6 Novogene
13.6.1 Novogene Company Information
13.6.2 Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
13.6.3 Novogene Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novogene Main Business Overview
13.6.5 Novogene Latest Developments
13.7 Geneseeq
13.7.1 Geneseeq Company Information
13.7.2 Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
13.7.3 Geneseeq Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Geneseeq Main Business Overview
13.7.5 Geneseeq Latest Developments
13.8 AmoyDx
13.8.1 AmoyDx Company Information
13.8.2 AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
13.8.3 AmoyDx Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AmoyDx Main Business Overview
13.8.5 AmoyDx Latest Developments
13.9 Burning Rock Medicine
13.9.1 Burning Rock Medicine Company Information
13.9.2 Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
13.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Burning Rock Medicine Main Business Overview
13.9.5 Burning Rock Medicine Latest Developments
13.10 NantHealth
13.10.1 NantHealth Company Information
13.10.2 NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
13.10.3 NantHealth Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NantHealth Main Business Overview
13.10.5 NantHealth Latest Developments
13.11 Personal Genome Diagnostics
13.11.1 Personal Genome Diagnostics Company Information
13.11.2 Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
13.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Personal Genome Diagnostics Main Business Overview
13.11.5 Personal Genome Diagnostics Latest Developments
13.12 GTH.O
13.12.1 GTH.O Company Information
13.12.2 GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
13.12.3 GTH.O Tumor Multigene Detection Kit Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 GTH.O Main Business Overview
13.12.5 GTH.O Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tumor Multigene Detection Kit Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tumor Multigene Detection Kit Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Reversible End Termination Sequencing
Table 4. Major Players of Semiconductor Sequencing
Table 5. Major Players of Combined Probe Anchored Polymerization Sequencing
Table 6. Global Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 7. Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Table 8. Global Tumor Multigene Detection Kit Revenue by Type (2018-2023) & ($ million)
Table 9. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2023)
Table 10. Global Tumor Multigene Detection Kit Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 12. Global Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Table 13. Global Tumor Multigene Detection Kit Revenue by Application (2018-2023)
Table 14. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2018-2023)
Table 15. Global Tumor Multigene Detection Kit Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Tumor Multigene Detection Kit Sales by Company (2018-2023) & (K Units)
Table 17. Global Tumor Multigene Detection Kit Sales Market Share by Company (2018-2023)
Table 18. Global Tumor Multigene Detection Kit Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Tumor Multigene Detection Kit Revenue Market Share by Company (2018-2023)
Table 20. Global Tumor Multigene Detection Kit Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution and Sales Area
Table 22. Players Tumor Multigene Detection Kit Products Offered
Table 23. Tumor Multigene Detection Kit Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tumor Multigene Detection Kit Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Tumor Multigene Detection Kit Sales Market Share Geographic Region (2018-2023)
Table 28. Global Tumor Multigene Detection Kit Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Tumor Multigene Detection Kit Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Tumor Multigene Detection Kit Sales Market Share by Country/Region (2018-2023)
Table 32. Global Tumor Multigene Detection Kit Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Tumor Multigene Detection Kit Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 35. Americas Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 36. Americas Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 38. Americas Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 39. Americas Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 40. APAC Tumor Multigene Detection Kit Sales by Region (2018-2023) & (K Units)
Table 41. APAC Tumor Multigene Detection Kit Sales Market Share by Region (2018-2023)
Table 42. APAC Tumor Multigene Detection Kit Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Tumor Multigene Detection Kit Revenue Market Share by Region (2018-2023)
Table 44. APAC Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 45. APAC Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 46. Europe Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 47. Europe Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 48. Europe Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 50. Europe Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 51. Europe Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Tumor Multigene Detection Kit
Table 59. Key Market Challenges & Risks of Tumor Multigene Detection Kit
Table 60. Key Industry Trends of Tumor Multigene Detection Kit
Table 61. Tumor Multigene Detection Kit Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Tumor Multigene Detection Kit Distributors List
Table 64. Tumor Multigene Detection Kit Customer List
Table 65. Global Tumor Multigene Detection Kit Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Tumor Multigene Detection Kit Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Tumor Multigene Detection Kit Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Tumor Multigene Detection Kit Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Tumor Multigene Detection Kit Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Tumor Multigene Detection Kit Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Tumor Multigene Detection Kit Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Tumor Multigene Detection Kit Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Foundation Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 81. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Roche Foundation Medicine Main Business
Table 83. Roche Foundation Medicine Latest Developments
Table 84. Illumina Inc. Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 85. Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 86. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Illumina Inc. Main Business
Table 88. Illumina Inc. Latest Developments
Table 89. Life Technologies Corporation Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 90. Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 91. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Life Technologies Corporation Main Business
Table 93. Life Technologies Corporation Latest Developments
Table 94. Thermo Fisher Scientific Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 95. Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 96. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Thermo Fisher Scientific Main Business
Table 98. Thermo Fisher Scientific Latest Developments
Table 99. Memorial Sloan Kettering Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 100. Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 101. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Memorial Sloan Kettering Main Business
Table 103. Memorial Sloan Kettering Latest Developments
Table 104. Novogene Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 105. Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 106. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novogene Main Business
Table 108. Novogene Latest Developments
Table 109. Geneseeq Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 110. Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 111. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Geneseeq Main Business
Table 113. Geneseeq Latest Developments
Table 114. AmoyDx Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 115. AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 116. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. AmoyDx Main Business
Table 118. AmoyDx Latest Developments
Table 119. Burning Rock Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 120. Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 121. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Burning Rock Medicine Main Business
Table 123. Burning Rock Medicine Latest Developments
Table 124. NantHealth Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 125. NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 126. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. NantHealth Main Business
Table 128. NantHealth Latest Developments
Table 129. Personal Genome Diagnostics Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 130. Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 131. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Personal Genome Diagnostics Main Business
Table 133. Personal Genome Diagnostics Latest Developments
Table 134. GTH.O Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 135. GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 136. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. GTH.O Main Business
Table 138. GTH.O Latest Developments
Table 1. Tumor Multigene Detection Kit Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tumor Multigene Detection Kit Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Reversible End Termination Sequencing
Table 4. Major Players of Semiconductor Sequencing
Table 5. Major Players of Combined Probe Anchored Polymerization Sequencing
Table 6. Global Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 7. Global Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Table 8. Global Tumor Multigene Detection Kit Revenue by Type (2018-2023) & ($ million)
Table 9. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2023)
Table 10. Global Tumor Multigene Detection Kit Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 12. Global Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Table 13. Global Tumor Multigene Detection Kit Revenue by Application (2018-2023)
Table 14. Global Tumor Multigene Detection Kit Revenue Market Share by Application (2018-2023)
Table 15. Global Tumor Multigene Detection Kit Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Tumor Multigene Detection Kit Sales by Company (2018-2023) & (K Units)
Table 17. Global Tumor Multigene Detection Kit Sales Market Share by Company (2018-2023)
Table 18. Global Tumor Multigene Detection Kit Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Tumor Multigene Detection Kit Revenue Market Share by Company (2018-2023)
Table 20. Global Tumor Multigene Detection Kit Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Tumor Multigene Detection Kit Producing Area Distribution and Sales Area
Table 22. Players Tumor Multigene Detection Kit Products Offered
Table 23. Tumor Multigene Detection Kit Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tumor Multigene Detection Kit Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Tumor Multigene Detection Kit Sales Market Share Geographic Region (2018-2023)
Table 28. Global Tumor Multigene Detection Kit Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Tumor Multigene Detection Kit Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Tumor Multigene Detection Kit Sales Market Share by Country/Region (2018-2023)
Table 32. Global Tumor Multigene Detection Kit Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Tumor Multigene Detection Kit Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 35. Americas Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 36. Americas Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 38. Americas Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 39. Americas Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 40. APAC Tumor Multigene Detection Kit Sales by Region (2018-2023) & (K Units)
Table 41. APAC Tumor Multigene Detection Kit Sales Market Share by Region (2018-2023)
Table 42. APAC Tumor Multigene Detection Kit Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Tumor Multigene Detection Kit Revenue Market Share by Region (2018-2023)
Table 44. APAC Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 45. APAC Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 46. Europe Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 47. Europe Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 48. Europe Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 50. Europe Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 51. Europe Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Tumor Multigene Detection Kit Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Tumor Multigene Detection Kit Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Tumor Multigene Detection Kit Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Tumor Multigene Detection Kit Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Tumor Multigene Detection Kit
Table 59. Key Market Challenges & Risks of Tumor Multigene Detection Kit
Table 60. Key Industry Trends of Tumor Multigene Detection Kit
Table 61. Tumor Multigene Detection Kit Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Tumor Multigene Detection Kit Distributors List
Table 64. Tumor Multigene Detection Kit Customer List
Table 65. Global Tumor Multigene Detection Kit Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Tumor Multigene Detection Kit Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Tumor Multigene Detection Kit Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Tumor Multigene Detection Kit Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Tumor Multigene Detection Kit Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Tumor Multigene Detection Kit Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Tumor Multigene Detection Kit Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Tumor Multigene Detection Kit Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Tumor Multigene Detection Kit Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Tumor Multigene Detection Kit Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Foundation Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Foundation Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 81. Roche Foundation Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Roche Foundation Medicine Main Business
Table 83. Roche Foundation Medicine Latest Developments
Table 84. Illumina Inc. Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 85. Illumina Inc. Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 86. Illumina Inc. Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Illumina Inc. Main Business
Table 88. Illumina Inc. Latest Developments
Table 89. Life Technologies Corporation Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 90. Life Technologies Corporation Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 91. Life Technologies Corporation Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Life Technologies Corporation Main Business
Table 93. Life Technologies Corporation Latest Developments
Table 94. Thermo Fisher Scientific Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 95. Thermo Fisher Scientific Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 96. Thermo Fisher Scientific Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Thermo Fisher Scientific Main Business
Table 98. Thermo Fisher Scientific Latest Developments
Table 99. Memorial Sloan Kettering Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 100. Memorial Sloan Kettering Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 101. Memorial Sloan Kettering Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Memorial Sloan Kettering Main Business
Table 103. Memorial Sloan Kettering Latest Developments
Table 104. Novogene Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 105. Novogene Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 106. Novogene Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novogene Main Business
Table 108. Novogene Latest Developments
Table 109. Geneseeq Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 110. Geneseeq Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 111. Geneseeq Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Geneseeq Main Business
Table 113. Geneseeq Latest Developments
Table 114. AmoyDx Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 115. AmoyDx Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 116. AmoyDx Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. AmoyDx Main Business
Table 118. AmoyDx Latest Developments
Table 119. Burning Rock Medicine Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 120. Burning Rock Medicine Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 121. Burning Rock Medicine Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Burning Rock Medicine Main Business
Table 123. Burning Rock Medicine Latest Developments
Table 124. NantHealth Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 125. NantHealth Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 126. NantHealth Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. NantHealth Main Business
Table 128. NantHealth Latest Developments
Table 129. Personal Genome Diagnostics Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 130. Personal Genome Diagnostics Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 131. Personal Genome Diagnostics Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Personal Genome Diagnostics Main Business
Table 133. Personal Genome Diagnostics Latest Developments
Table 134. GTH.O Basic Information, Tumor Multigene Detection Kit Manufacturing Base, Sales Area and Its Competitors
Table 135. GTH.O Tumor Multigene Detection Kit Product Portfolios and Specifications
Table 136. GTH.O Tumor Multigene Detection Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. GTH.O Main Business
Table 138. GTH.O Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tumor Multigene Detection Kit
Figure 2. Tumor Multigene Detection Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Multigene Detection Kit Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tumor Multigene Detection Kit Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tumor Multigene Detection Kit Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Reversible End Termination Sequencing
Figure 10. Product Picture of Semiconductor Sequencing
Figure 11. Product Picture of Combined Probe Anchored Polymerization Sequencing
Figure 12. Global Tumor Multigene Detection Kit Sales Market Share by Type in 2022
Figure 13. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2023)
Figure 14. Tumor Multigene Detection Kit Consumed in Companion Diagnostics
Figure 15. Global Tumor Multigene Detection Kit Market: Companion Diagnostics (2018-2023) & (K Units)
Figure 16. Tumor Multigene Detection Kit Consumed in Early Cancer Screening
Figure 17. Global Tumor Multigene Detection Kit Market: Early Cancer Screening (2018-2023) & (K Units)
Figure 18. Tumor Multigene Detection Kit Consumed in Drug Discovery
Figure 19. Global Tumor Multigene Detection Kit Market: Drug Discovery (2018-2023) & (K Units)
Figure 20. Tumor Multigene Detection Kit Consumed in Other
Figure 21. Global Tumor Multigene Detection Kit Market: Other (2018-2023) & (K Units)
Figure 22. Global Tumor Multigene Detection Kit Sales Market Share by Application (2022)
Figure 23. Global Tumor Multigene Detection Kit Revenue Market Share by Application in 2022
Figure 24. Tumor Multigene Detection Kit Sales Market by Company in 2022 (K Units)
Figure 25. Global Tumor Multigene Detection Kit Sales Market Share by Company in 2022
Figure 26. Tumor Multigene Detection Kit Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Tumor Multigene Detection Kit Revenue Market Share by Company in 2022
Figure 28. Global Tumor Multigene Detection Kit Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 31. Americas Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 32. APAC Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 33. APAC Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 34. Europe Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 35. Europe Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 38. Americas Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 39. Americas Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 40. Americas Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 41. Americas Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 42. United States Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Tumor Multigene Detection Kit Sales Market Share by Region in 2022
Figure 47. APAC Tumor Multigene Detection Kit Revenue Market Share by Regions in 2022
Figure 48. APAC Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 49. APAC Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 50. China Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 58. Europe Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 59. Europe Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 60. Europe Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 61. Germany Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 70. Egypt Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit in 2022
Figure 76. Manufacturing Process Analysis of Tumor Multigene Detection Kit
Figure 77. Industry Chain Structure of Tumor Multigene Detection Kit
Figure 78. Channels of Distribution
Figure 79. Global Tumor Multigene Detection Kit Sales Market Forecast by Region (2024-2029)
Figure 80. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Tumor Multigene Detection Kit
Figure 2. Tumor Multigene Detection Kit Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tumor Multigene Detection Kit Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Tumor Multigene Detection Kit Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tumor Multigene Detection Kit Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Reversible End Termination Sequencing
Figure 10. Product Picture of Semiconductor Sequencing
Figure 11. Product Picture of Combined Probe Anchored Polymerization Sequencing
Figure 12. Global Tumor Multigene Detection Kit Sales Market Share by Type in 2022
Figure 13. Global Tumor Multigene Detection Kit Revenue Market Share by Type (2018-2023)
Figure 14. Tumor Multigene Detection Kit Consumed in Companion Diagnostics
Figure 15. Global Tumor Multigene Detection Kit Market: Companion Diagnostics (2018-2023) & (K Units)
Figure 16. Tumor Multigene Detection Kit Consumed in Early Cancer Screening
Figure 17. Global Tumor Multigene Detection Kit Market: Early Cancer Screening (2018-2023) & (K Units)
Figure 18. Tumor Multigene Detection Kit Consumed in Drug Discovery
Figure 19. Global Tumor Multigene Detection Kit Market: Drug Discovery (2018-2023) & (K Units)
Figure 20. Tumor Multigene Detection Kit Consumed in Other
Figure 21. Global Tumor Multigene Detection Kit Market: Other (2018-2023) & (K Units)
Figure 22. Global Tumor Multigene Detection Kit Sales Market Share by Application (2022)
Figure 23. Global Tumor Multigene Detection Kit Revenue Market Share by Application in 2022
Figure 24. Tumor Multigene Detection Kit Sales Market by Company in 2022 (K Units)
Figure 25. Global Tumor Multigene Detection Kit Sales Market Share by Company in 2022
Figure 26. Tumor Multigene Detection Kit Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Tumor Multigene Detection Kit Revenue Market Share by Company in 2022
Figure 28. Global Tumor Multigene Detection Kit Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Tumor Multigene Detection Kit Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 31. Americas Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 32. APAC Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 33. APAC Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 34. Europe Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 35. Europe Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Tumor Multigene Detection Kit Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Tumor Multigene Detection Kit Revenue 2018-2023 ($ Millions)
Figure 38. Americas Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 39. Americas Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 40. Americas Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 41. Americas Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 42. United States Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Tumor Multigene Detection Kit Sales Market Share by Region in 2022
Figure 47. APAC Tumor Multigene Detection Kit Revenue Market Share by Regions in 2022
Figure 48. APAC Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 49. APAC Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 50. China Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 58. Europe Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 59. Europe Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 60. Europe Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 61. Germany Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Tumor Multigene Detection Kit Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Tumor Multigene Detection Kit Sales Market Share by Application (2018-2023)
Figure 70. Egypt Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Tumor Multigene Detection Kit Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Tumor Multigene Detection Kit in 2022
Figure 76. Manufacturing Process Analysis of Tumor Multigene Detection Kit
Figure 77. Industry Chain Structure of Tumor Multigene Detection Kit
Figure 78. Channels of Distribution
Figure 79. Global Tumor Multigene Detection Kit Sales Market Forecast by Region (2024-2029)
Figure 80. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Tumor Multigene Detection Kit Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Tumor Multigene Detection Kit Revenue Market Share Forecast by Application (2024-2029)
